Professional
Added to YB: 2024-05-20
Pitch date: 2024-05-15
ZTS [bullish]
Zoetis Inc.
-27.39%
current return
Author Info
No bio for this author
Company Info
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.
Market Cap
$53.3B
Pitch Price
$169.71
Price Target
N/A
Dividend
1.75%
EV/EBITDA
14.33
P/E
20.38
EV/Sales
6.23
Sector
Pharmaceuticals
Category
value
Aristotle Capital Core Equity Portfolio Holding: Zoetis Inc.
ZTS: Detracted in Q despite solid Librela launch for canine osteoarthritis in US. Mgmt addressed low incidence of ataxia safety concerns. Trades below 5yr avg on pet ownership & livestock protein demand tailwinds.
Read full article (1 min)